Search research articles
Contact Us
Filters
Showing results (71-80 of 126) with videos related to
Page
of 13
Sort By:
NPJ Precision Oncology
|
July 16, 2024
Antibiotics are associated with worse outcomes in lung cancer patients treated with chemotherapy and immunotherapy
Arielle Elkrief, Eder Orlando Méndez-Salazar, Jade Maillou, et al.
Neuro-Oncology Advances
|
April 7, 2023
Phase II multicenter trial combining nivolumab and radiosurgery for NSCLC and RCC brain metastases
Philip Wong, Laura Masucci, Marie Florescu, et al.
Journal for Immunotherapy of Cancer
|
August 4, 2025
Improved survival in advanced melanoma patients treated with fecal microbiota transplantation using healthy donor stool in combination with anti-PD1: final results of the MIMic phase 1 trial
Danial Khan Hadi, Kelly J Baines, Behnam Jabbarizadeh, et al.
Trials
|
December 13, 2025
Fecal microbiota transplantation to reduce immune activation in ART-treated people with HIV with low CD4/CD8 ratio: protocol for the single-blind, randomized, placebo-controlled Gutsy study (CIHR/CTN PT038)
Stéphane Isnard, Carolina A Berini, Seema Nair Parvathy, et al.
Cell Reports
|
September 1, 2021
Combined single-cell transcriptional, translational, and genomic profiling reveals HIV-1 reservoir diversity
Gérémy Sannier, Mathieu Dubé, Caroline Dufour, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 17, 2021
A Uniform Computational Approach Improved on Existing Pipelines to Reveal Microbiome Biomarkers of Nonresponse to Immune Checkpoint Inhibitors
Fyza Y Shaikh, James R White, Joell J Gills, et al.
Journal of Translational Medicine
|
May 6, 2025
Computational analysis of whole slide images predicts PD-L1 expression and progression-free survival in immunotherapy-treated non-small cell lung cancer patients
Abdou Khadir Dia, Alona Kolnohuz, Sevinj Yolchuyeva, et al.
Oncoimmunology
|
September 16, 2020
Trial watch : the gut microbiota as a tool to boost the clinical efficacy of anticancer immunotherapy
Romain Daillère, Lisa Derosa, Mélodie Bonvalet, et al.
Journal for Immunotherapy of Cancer
|
April 3, 2026
Targeting PAR-2 with a negative allosteric modulator increases tumor antigen presentation and potentiates anti-PD-1 immunotherapy
Samya Aouad, Maleck Kadiri, David Allard, et al.
Nature
|
July 8, 2026
Diet-microbiome synergy underlies obesity-associated immunotherapy efficacy
Lysanne Desharnais, Anikka Swaby, Meriem Messaoudene, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 126) with videos related to
Sort By:
Page
of 13
NPJ Precision Oncology
|
July 16, 2024
Antibiotics are associated with worse outcomes in lung cancer patients treated with chemotherapy and immunotherapy
Arielle Elkrief, Eder Orlando Méndez-Salazar, Jade Maillou, et al.
Neuro-Oncology Advances
|
April 7, 2023
Phase II multicenter trial combining nivolumab and radiosurgery for NSCLC and RCC brain metastases
Philip Wong, Laura Masucci, Marie Florescu, et al.
Journal for Immunotherapy of Cancer
|
August 4, 2025
Improved survival in advanced melanoma patients treated with fecal microbiota transplantation using healthy donor stool in combination with anti-PD1: final results of the MIMic phase 1 trial
Danial Khan Hadi, Kelly J Baines, Behnam Jabbarizadeh, et al.
Trials
|
December 13, 2025
Fecal microbiota transplantation to reduce immune activation in ART-treated people with HIV with low CD4/CD8 ratio: protocol for the single-blind, randomized, placebo-controlled Gutsy study (CIHR/CTN PT038)
Stéphane Isnard, Carolina A Berini, Seema Nair Parvathy, et al.
Cell Reports
|
September 1, 2021
Combined single-cell transcriptional, translational, and genomic profiling reveals HIV-1 reservoir diversity
Gérémy Sannier, Mathieu Dubé, Caroline Dufour, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 17, 2021
A Uniform Computational Approach Improved on Existing Pipelines to Reveal Microbiome Biomarkers of Nonresponse to Immune Checkpoint Inhibitors
Fyza Y Shaikh, James R White, Joell J Gills, et al.
Journal of Translational Medicine
|
May 6, 2025
Computational analysis of whole slide images predicts PD-L1 expression and progression-free survival in immunotherapy-treated non-small cell lung cancer patients
Abdou Khadir Dia, Alona Kolnohuz, Sevinj Yolchuyeva, et al.
Oncoimmunology
|
September 16, 2020
Trial watch : the gut microbiota as a tool to boost the clinical efficacy of anticancer immunotherapy
Romain Daillère, Lisa Derosa, Mélodie Bonvalet, et al.
Journal for Immunotherapy of Cancer
|
April 3, 2026
Targeting PAR-2 with a negative allosteric modulator increases tumor antigen presentation and potentiates anti-PD-1 immunotherapy
Samya Aouad, Maleck Kadiri, David Allard, et al.
Nature
|
July 8, 2026
Diet-microbiome synergy underlies obesity-associated immunotherapy efficacy
Lysanne Desharnais, Anikka Swaby, Meriem Messaoudene, et al.
Page
of 13